top of page
hero-bg.png

MSN Pharmalab Pharmaceutical Manufacturing Plant

Potato Processing Complex.jpg
Photo Sources: invest.gov.kz

PROJECT ID

172025142

SECTOR

Healthcare & Pharmaceuticals

PROJECT PHASE

Engineering Design & Planning

LOCATION

Almaty Region, Kazakhstan

START DATE

7/1/2025

INVESTMENT VALUE

$ 60 M

Active

gifyyyyy.gif

Verified

Last Updated: 6 July 2026

Publication: 15 July 2025

PROJECT DESCRIPTION

The Indian pharmaceutical company MSN Group is partnering with Kazakhstan’s KFK Medservice Plus LLPto establish a full-cycle pharmaceutical manufacturing facility in the Almaty Region of Kazakhstan. The project involves the construction of a modern plant under the brand MSN Pharmalab, focusing on the production of solid dosage forms, including tablets and capsules. It aims to localize the entire production chain — from research and development to packaging and distribution. The facility will be export-oriented and is expected to generate over 300 jobs. The project is considered strategically important for Kazakhstan's healthcare industry and ... Read more

Involved Companies & Contacts

INVOLVED COMPANIES & CONTACTS

COMPANY 1 INFO

COMPANY:

░░░░░░░░░░░░░░░░░░░░░░░░

ROLE:

░░░░░░░░░░░░░░░░░░░░░░░

ADDRESS:

░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░

PHONE:

░░░░░░░░░░░░░

EMAIL:

5. party1CompanyEmailText

WEBSITE:

░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░

OTHER LINKS:

░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░

KEY CONTACTS

NAME:

░░░░░░░░░░░░░░░░░░

POSITION:

░░░░░░

PHONE:

party1Contact1PhoneText

EMAIL:

░░░░░░░░░░░░░░░░░░

LINK:

░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░

NAME:

party1Contact2NameText

POSITION:

party1Contact2PositionText

PHONE:

party1Contact2PhoneText

EMAIL:

party1Contact2EmailText

LINK:

party1Contact2LinkText

COMPANY 2 INFO

COMPANY:

░░░░░░░░░░░░░

ROLE:

░░░░░░░░░░░░

ADDRESS:

░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░

PHONE:

░░░░░░░░░░░░░░░░

EMAIL:

░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░

WEBSITE:

░░░░░░░░░░░░░░░░░░░░░░░

OTHER LINKS:

7. party1CompanyWebsiteText

KEY CONTACTS

NAME:

░░░░░░░░░░░░░░░░░░

POSITION:

░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░

PHONE:

░░░░░░░░░░░░░░

EMAIL:

░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░

LINK:

party1Contact1LinkText

NAME:

party1Contact2NameText

POSITION:

party1Contact2PositionText

PHONE:

party1Contact2PhoneText

EMAIL:

party1Contact2EmailText

LINK:

party1Contact2LinkText

COMPANY 3 INFO

COMPANY:

░░░░░░░░░░░░░░░

ROLE:

░░░░░░░░░░░░░░░░░░░░░░░

ADDRESS:

░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░

PHONE:

░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░

EMAIL:

░░░░░░░░░░░░░░░░

WEBSITE:

░░░░░░░░░░░░░░░░░░░░

OTHER LINKS:

░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░

KEY CONTACTS

NAME:

░░░░░░░░░░░░░░░░

POSITION:

░░░░░░░░░░░░░

PHONE:

party1Contact1PhoneText

EMAIL:

░░░░░░░░░░░░░░░░░░░░░░░░░

LINK:

░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░

NAME:

░░░░░░░░░░░░░░░░

POSITION:

░░░░░░░░░░░░

PHONE:

party1Contact2PhoneText

EMAIL:

░░░░░░░░░░░░░░░░░░░░░░░░

LINK:

░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░

Location

Locations shown on the map are for indicative purposes and may vary from actual locations.

Other important details

· The plant will focus on export to Central Asia, CIS, and European markets.

· Includes R&D component for formulation and process development.

· Supported under Kazakhstan’s investment incentives program.

· Project aligns with Kazakhstan’s healthcare localization and pharmaceutical security goals.

· MSME technology will be transferred and adapted for local GMP-compliant production.

Sources

░░░░░░░░░░░░░░

░░░░░░░░░░░░░░

░░░░░░░░░░░░░░

░░░░░░░░░░░░░░

Similar Projects

bottom of page